Consent form developed for infertility therapy

By Karla Gale

NEW YORK (Reuters Health) - The Society for Assisted Reproductive Technology (SART) has developed a comprehensive document for doctors to use when obtaining informed consent from patients seeking infertility treatment.

“This is our compilation of the important elements of informed consent that should be reviewed with patients,” incoming SART president Dr. Elizabeth Ginsburg said in an interview with Reuters Health. “It’s designed to be used ‘as is,’ or it can be used by clinics to adjust their own consent forms.”

As presented at the American Society for Reproductive Medicine annual meeting in San Francisco, the form explains the different options available to patients, including, among others, in vitro fertilization and embryo frozen storage or “cryopreservation.”

“From the standpoint of informed consent I don’t think there is any area of medicine that is more complicated than assisted reproductive technology,” said Ginsburg, a reproductive endocrinologist from Brigham and Women’s Hospital in Boston. “It involves not just the risks of treatment, but also potential unknown risk to offspring, since this is a relatively new field.”

The document also goes into ethical, legal, and psychosocial issues of assisted reproductive technology.

The document will be available to SART members at www.sart.org/.

Source

--------------------------------------------------------------------------------------------
Related Posts:


By Karla Gale NEW YORK (Reuters Health) - Freezing embryos before undergoing cancer treatment that may cause infertility is as successful for women with cancer as it is for women without cancer, new study findings indicate. The investigators, who presented their findings this week at the 64th annual meeting of the American Society of Reproductive Medicine in

Full Post: Embryo preservation often works for cancer patients
--------------------------------------------------------------------------------------------

By Julie Steenhuysen CHICAGO (Reuters) - As many as 7 percent of patients from a large U.S. hospital system had enough radiation exposure from CT scans during their lifetime to slightly raise their risk of cancer, U.S. researchers said on Tuesday. The finding is part of an effort to develop tools that help doctors assess a patient’s

Full Post: U.S. study weighs lifetime risks from CT scans
--------------------------------------------------------------------------------------------

By Karla Gale NEW YORK (Reuters Health) - Treatment with paroxetine (Paxil), which belongs to the selective serotonin reuptake inhibitor (SSRI) class of antidepressant drugs, increases DNA fragmentation in sperm, according to research presented today at the 64th annual meeting of the American Society for Reproductive Medicine in San Francisco. Although the study did not directly evaluate

Full Post: Antidepressant treatment may reduce male fertility
--------------------------------------------------------------------------------------------

SANTIAGO (Reuters) - Chile’s public health system may have failed to notify at least 512 people that they were infected with the HIV virus, Health Minister Alvaro Erazo said Thursday amid a mushrooming AIDS scandal. Appearing before Chile’s Lower House of Congress, Erazo said public health system records could not confirm that some 244 people infected

Full Post: Chile says 512 may be infected in HIV scandal
--------------------------------------------------------------------------------------------

By Susan Heavey WASHINGTON (Reuters) - U.S. health regulators are questioning whether clinical trials proposed by ImClone Systems and Amgen Inc will be adequate to show that patients with a certain type of gene are more likely to be helped by two cancer drugs, according to documents released on Friday. Early research has indicated that patients with

Full Post: FDA questions Lilly, Amgen cancer drug trials

Site Navigation

Most Read

Search